SCU Clinical Trials
Interested in staying healthy while you age?
SCU research partner Ki-Whole Enterprises are investigating the use of a natural marine product on body composition, muscular strength and inflammation in women – all important in staying healthy.
They are seeking non-smoking generally healthy women (aged 40-65 years) who are pre-menopausal or post-menopausal for our latest 22-week clinical trial.
Maintaining a healthy body composition, particularly skeletal muscle mass, is a critical factor in successful ageing. Changes to our body composition can begin during the fourth decade of life; supplements that are found to help maintain a healthy body composition could play an important role in healthy ageing along with a healthy lifestyle.
Participants who have met all inclusion criteria will attend clinical appointments on three occasions at the Southern Cross University’s Lismore campus. Participants will receive an assessment of their body composition and muscular strength, along with a measure of their blood fatty acids and several inflammation markers.
This trial will NOT suit those with a shellfish allergy, anyone experiencing menopausal symptoms or vegans.
This clinical trial has approval from the Southern Cross University Human Research Ethics Committee (ECN: 2020-117).
If you are interested in participating, please contact the clinical trial coordinator Shelley Robinson.
Following several successful studies, we are continuing to investigate the effects of a natural marine product on osteoarthritis.
They are seeking non-smoking men (aged 45–75 years of age) who have osteoarthritis of the knee, but are otherwise healthy.
Participants who have met the inclusion criteria will complete all required documentation, including research questionnaires via an online format during the 6-week study. Study participants will NOT be required to attend in person.
This clinical trial has approval from the Southern Cross University Human Research Ethics Committee (ECN-2021-045).
If you are interested in participating, please contact the clinical trial coordinator Shelley Robinson via email or by clicking on the 'Register now' button below.
Southern Cross University health researchers are conducting a research project titled "A preliminary investigation on the effects of intermittent exposure to hypoxia on glucose homeostasis".
We are investigating the use of intermittent hypoxia on blood glucose levels and other health-related measures in adults with high fasting blood glucose or type 2 diabetes.
We are seeking males and females aged 18 to 65 years old with high-than-normal fasting blood glucose or have been diagnosed with type 2 diabetes who are overweight or obese for our latest clinical trial.
Many individuals with type 2 diabetes may be unable to exercise due to time constraints or are unable due to conditions such as arthritis, heart disease and other ailments.
In Phase 1 participants who meet all inclusion criteria will attend one clinical appointment a week for four weeks at the Southern Cross University’s Gold Coast campus. In Phase 2, participants will attend 3 clinical appointments (1 hour each) per week for six weeks. Measures of your body composition, blood glucose, blood pressure and other measures will be made.
Individuals with type 2 diabetes who are physically active are NOT eligible to participate.
This clinical trial has approval from the Southern Cross University Human Research Ethics Committee (Approval number: 2019/367).
If you are interested in participating, please contact the clinical trial coordinator Jessica.